The following is a schedule of financial highlights for the three months ended March 31, 2026 and 2025:


	Three months ended March 31, 2026			Three months ended March 31, 2025
Per Share Data: (a)
Net asset value, beginning of year	$	18.26		$	18.20
Net investment income		0.33			0.41
Net realized and unrealized gain (loss)		(0.02	)		(0.04	)
Net increase in net assets resulting from operations		0.31			0.37
Distributions to stockholders:
From distributable earnings		(0.33	)		(0.41	)
From return of capital		(0.08	)		—
Net asset value, end of period	$	18.16		$	18.16
Per share market value, end of period	$	14.31		$	16.86
Total Return (b)(c)		0.79	%		6.82	%
Net assets, end of period	$	990,750		$	990,485
Shares outstanding, end of period		54,554,634			54,554,634
Ratios to average net assets (c):
Net investment income		1.79	%		2.23	%
Operating expenses	1.51%*			1.53%*
Interest and other credit facility expenses		1.65	%		1.60	%
Total expenses	3.16%*			3.13%*
Average debt outstanding	$	1,117,287		$	1,010,398
Portfolio turnover ratio		5.6	%		9.7	%

(a)

Calculated using the average shares outstanding method.

(b)

Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2025 and December 31, 2024 was $15.46 and $16.16, respectively. Total return does not include a sales load.

(c)

Not annualized for periods less than one year.

* The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the three months ended March 31, 2026 and 2025, the ratios of operating expenses to average net assets would be 1.51% and 1.53%, respectively, without the performance-based incentive fee waiver. For the three months ended March 31, 2026 and 2025, the ratios of total expenses to average net assets would be 3.16% and 3.13%, respectively, without the performance-based incentive fee waiver.